Loading...
•
Jul 02, 2021
STAAR Surgical Q2 2021 Earnings Report
STAAR Surgical's Q2 2021 earnings reflected record net sales and ICL sales, driven by strong global ICL unit growth and positive sales in major markets.
Key Takeaways
STAAR Surgical reported record second-quarter net sales of $62.4 million, a 77% increase year-over-year, driven by ICL sales growth of 93%. The company raised its full-year net sales outlook to a range of $227 million to $230 million.
Record quarterly net sales of $62.4 million, up 77% year-over-year.
Record quarterly ICL sales of $59.2 million, up 93% year-over-year.
Record quarterly ICL units, up 79% year-over-year.
Net income of $0.17 per share, compared to a net loss of ($0.03) per share in the prior year quarter.
Revenue by Segment
Forward Guidance
STAAR Surgical raised its outlook for full-year fiscal 2021 net sales to a range of $227 million to $230 million.
Positive Outlook
- Increased sales outlook for fiscal year 2021 represents approximately 40% growth year over year.
- ICL unit growth in China up 65%.
- ICL unit growth in Japan up 95%.
- ICL unit growth in Korea up 57%.
- ICL unit growth in the U.S. up 255%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...